Entegrion, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.entegrion.com
Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy
- Conditions
- Coagulopathy
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2021-01-07
- Lead Sponsor
- Entegrion, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT03700723
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸Washington University St. Louis, Saint Louis, Missouri, United States
🇺🇸Carolinas Medical Center, Charlotte, North Carolina, United States
Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation Parameters
- Conditions
- Hemostasis Monitoring
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Entegrion, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT03679286
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
🇺🇸Ohio State University, Columbus, Ohio, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy Volunteers
- Conditions
- Coagulation
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Entegrion, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT03133351
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
- Conditions
- Coagulation Defects
- Interventions
- Drug: Spray-dried S/D-treated plasma
- First Posted Date
- 2012-05-02
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- Entegrion, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT01589666
- Locations
- 🇺🇸
Vince & Associates Clinical Research, Overland Park, Kansas, United States